Connect with us

Globe Trotting

Changes in Roche’s board of directors and corporate executive committee

Roche has announced that Peter Voser, a member of the board of directors of Roche Holding Ltd. since 2011, has decided to step down as a member of the board of directors of Roche due to his additional role as interim CEO of ABB. The company has also announced the following changes to the corporate executive committee.

Michael Heuer, CEO Roche Diagnostics and member of the corporate executive committee, will retire as planned at the end of July. The board of directors has appointed Thomas Schinecker, currently head of centralized and point-of-care solutions, as CEO Roche Diagnostics and a member of the corporate executive committee with effect from August 1, 2019.

Stephan Feldhaus, head of group communications and member of Roche’s enlarged corporate executive committee, has decided to continue his career outside the company as of the end of September 2019. He will be succeeded on October 1, 2019 by Barbara Schädler, currently head of communications and public affairs at E.ON SE. Barbara Schädler will report to CEO Severin Schwan as a member of the enlarged corporate executive committee.

Copyright © 2024 Medical Buyer

error: Content is protected !!